Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Goodyear Tire & Rubber Co (GT) vs GeneDx Holdings Corp (WGS) Price & Performance

Goodyear Tire & Rubber CoTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Goodyear Tire & Rubber Co vs GeneDx Holdings Corp — how do they compare? Goodyear Tire & Rubber Co trades at $7.12 (market cap $1.94B), while GeneDx Holdings Corp trades at $65.28 (market cap $1.96B). The key difference: Goodyear Tire & Rubber Co and GeneDx Holdings Corp are close in size by market cap. Which is the better fit depends on your goals.

GTWGS
Market Cap
$1.94B$1.96B
Sector
Consumer CyclicalTechnology
52-Week High
$11.54$167.51
52-Week Low
$5.58$34.51
Enterprise Value
$9.25B$1.96B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Goodyear Tire & Rubber Co

Goodyear Tire & Rubber (GT) trades at $6.66, up 0.3% with neutral technical signals. The stock shows mixed fundamentals with attractive valuation ratios (P/E 4.69, P/B 0.64) but negative profitability (ROE -52.56%, net margin -11.64%). Recent Q1 2026 earnings beat estimates despite a loss, while the company transitions to S&P SmallCap 600. Cash flow improved in 2025 with $46M net inflow, though revenue declined to $18.28B.

Outlook remains challenging with declining revenue and negative margins, though deep value metrics and analyst consensus target of $8.75 suggest upside potential. Key risks include persistent operational headwinds, weak tire demand, and high debt levels. The Goodyear Forward program and lunar tire contract provide strategic catalysts amid competitive pressures.

GeneDx Holdings Corp

GeneDx Holdings Corp. (WGS) trades at $65.785, up 5.37% today, but faces a bearish technical signal with the stock near resistance at $65. The company shows mixed fundamentals with strong revenue growth to $427.54M in 2025 but a net loss of -$21.02M, while analyst consensus remains bullish with a $75.40 price target. Recent news highlights multiple class-action lawsuits alleging securities fraud tied to a 49% stock decline and acquisition underperformance, creating significant investor uncertainty.

The outlook is highly conflicted: strong analyst buy ratings and recent earnings beats contrast with deepening losses, negative cash flow projections for 2026, and legal overhangs. Key risks include litigation outcomes, profitability challenges, and execution missteps, but the stock offers potential upside if the company can stabilize margins and resolve legal issues amid high institutional skepticism.

Returns comparison

Trailing returns across standard periods

About Goodyear Tire & Rubber Co

Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment.

Read more on GT

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS